The Use and Impact on Treatment Decision of the 21-Gene Recurrence Score Assay for Patients With HR+/HER2− Early Breast Cancer in Portugal: A Nationwide Retrospective Cohort Study
Clinical Breast Cancer · 2026
DOI: 10.1016/j.clbc.2025.09.013 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Breast Cancer, 2026. Verfasst von Teresa Gantes Padrão und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Hospital da Luz Lisboa, Lisbon, Portugal. Electronic address: teresa.gantes.padrao@fundacaochampalimaud.pt. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Recurrence, Local, Biomarkers, Tumor, Clinical Decision-Making. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Hospital da Luz Lisboa, Lisbon, Portugal. Electronic address: teresa.gantes.padrao@fundacaochampalimaud.pt.
- Department of Medical Oncology, Instituto Português de Oncologia Lisboa, Lisbon, Portugal.
- Department of Medical Oncology, Hospital Lusíadas Lisboa, Lisbon, Portugal.
- Department of Medical Oncology, Hospital CUF Lisboa, Lisbon, Portugal.
- Department of Medical Oncology, ULS do Arco Ribeirinho, Barreiro, Portugal.
- Department of Medical Oncology, Hospital CUF Porto, Porto, Portugal.
Zitieren
APA
Padrão, T. G., Pessoa, D., Luís, J. A., Costa, D. A., Fontes E Sousa, M., Pina, Í., de Sousa, S. P., Cardoso, D., Bento, S., Simões, J., Ferreira, A., Cunha, R., Martins-Branco, D., Domingues, T. D., Passos-Coelho, J. L., & Portuguese 21-Gene Recurrence Score Assay National Study (2026). The Use and Impact on Treatment Decision of the 21-Gene Recurrence Score Assay for Patients With HR+/HER2− Early Breast Cancer in Portugal: A Nationwide Retrospective Cohort Study. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.09.013
Vancouver
Padrão TG, Pessoa D, Luís JA, Costa DA, Fontes E Sousa M, Pina Í, et al. The Use and Impact on Treatment Decision of the 21-Gene Recurrence Score Assay for Patients With HR+/HER2− Early Breast Cancer in Portugal: A Nationwide Retrospective Cohort Study. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2025.09.013
BibTeX
@article{Padro2026,
author = {Padrão, Teresa Gantes and Pessoa, Diana and Luís, Joana Alves and Costa, Diogo Alpuim and Fontes E Sousa, Mário and Pina, Ídilia and de Sousa, Susana Palma and Cardoso, Débora and Bento, Sandra and Simões, Joana and Ferreira, Ana and Cunha, Renato and Martins-Branco, Diogo and Domingues, Tiago Dias and Passos-Coelho, José Luís and Portuguese 21-Gene Recurrence Score Assay National Study, Portuguese 21-Gene Recurrence Score Assay National Study},
title = {The Use and Impact on Treatment Decision of the 21-Gene Recurrence Score Assay for Patients With HR+/HER2− Early Breast Cancer in Portugal: A Nationwide Retrospective Cohort Study},
journal = {Clinical Breast Cancer},
year = {2026},
doi = {10.1016/j.clbc.2025.09.013}
}
EUVIMED